[1] F. Bray, J. Ferlay, I. Soerjomataram, R.L. Siegel, L.A. Torre, A. Jemal, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, C.A. Cancer J. Clin. 68(6) (2018) 394–424. doi:10.3322/caac.21492.
[2] A. McGuigan, P. Kelly, R.C. Turkington, C. Jones, H.G. Coleman, R.S. McCain, Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes, World J. Gastroenterol. 24(43) (2018) 4846–4861. doi:10.3748/wjg.v24.i43.4846.
[3] M. Ilic, I. Ilic, Epidemiology of pancreatic cancer, World J. Gastroenterol. 22(44) (2016) 9694–9705. doi:10.3748/wjg.v22.i44.9694.
[4] M.T. Moyer, R.R. Gaffney, Pancreatic adenocarcinoma, N. Engl. J. Med. 371(22) (2014) 2140. doi:10.1056/NEJMc1412266.
[5] S. Palacio, P.J. Hosein, I. Reis, et al, The nab-paclitaxel/gemcitabine regimen for patients with refractory advanced pancreatic adenocarcinoma, J. Gastrointest. Oncol. 9(1) (2018) 135–139. doi:10.21037/jgo.2017.10.12.
[6] F.T. Bosman, F. Carneiro, R.H. Hruban, N.D. Theise. WHO Classification of Tumours of the Digestive System (2010). IARC Press, Lyon.
[7] A.C. de Vries, N.C. van Grieken, C.W. Looman, et al, Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands, Gastroenterology 134(4) (2008) 945–952. doi:10.1053/j.gastro.2008.01.071.
[8] A.B. Mariotto, K.R. Yabroff, Y. Shao, E.J. Feuer, M.L. Brown, Projections of the cost of cancer care in the United States: 2010–2020, J. Natl. Cancer Inst. 103(2) (2011) 117–128 doi:10.1093/jnci/djq495.
[9] H. Wang, J. Li, X. Yu, S.Y. Li, Integrated traditional Chinese and conventional medicine in treatment of severe community-acquired pneumonia: study protocol for a randomized placebo-controlled trial, Trials 19(1) (2018) 620. doi:10.1186/s13063-018-3005-9.
[10] L. Bai, J. Zhao, J. Gao, et al, Effects of Shuganjianpihuatanxingqi decoction on mild subclinical hypothyroidism: a SPIRIT compliant randomized controlled trial study protocol, Med. (Baltim.) 97(45) (2018) e13183. doi:10.1097/MD.0000000000013183.
[11] Y. Zhang, Y. Liu, R. Song, et al, Validating traditional Chinese syndrome features in varied stages of chronic gastritis malignant transformation: study protocol for a cross-sectional study, BMJ Open 8(8) (2018) e020939. doi:10.1136/bmjopen-2017-020939.
[12] Y. Zhang, Y. Liu, Y. Li, et al, Hierarchical and complex system entropy clustering analysis based validation for traditional Chinese medicine syndrome patterns of chronic atrophic gastritis, J. Altern. Complement. Med. 25(11) (2019) 1130–1139 doi:10.1089/acm.2017.0386.
[13] M. Liu, Z. Liu, Overview of clinical study on traditional Chinese medicine invigorating spleen and stomach, promoting blood circulation and remove blood stasis in treatment of chronic atrophic gastritis, Zhongguo Zhong Yao Za Zhi 37(22) (2012) 3361–3364.
[14] J. Xu, W. Shen, B. Pei, et al, Xiao Tan He Wei Decoction reverses MNNG-induced precancerous lesions of gastric carcinoma in vivo and vitro: regulation of apoptosis through NF-κB pathway, Biomed. Pharmacother. 108 (2018) 95–102. doi:10.1016/j.biopha.2018.09.012.
[15] J. Zeng, R. Yan, H. Pan, et al, Weipixiao attenuate early angiogenesis in rats with gastric precancerous lesions, B.M.C. Complement. Altern. Med. 18(1) (2018) 250. doi:10.1186/s12906-018-2309-3.
[16] J. Yin, J. Yi, C. Yang, et al, Weiqi decoction attenuated chronic atrophic gastritis with precancerous lesion through regulating microcirculation disturbance and HIF-1α signaling pathway, Evid. Based Complement. Alternat. Med. (2019) 2651037. doi:10.1155/2019/2651037.
[17] X. Zhao, X.H. Yu, G.Y. Zhang, et al, Aqueous Extracts of Cordyceps kyushuensis Kob Induce Apoptosis to Exert Anticancer Activity, BioMed Res. Int. 2018 (2018) 8412098 doi:10.1155/2018/8412098.
[18] H. Xie, X. Li, Y. Chen, M. Lang, Z. Shen, L. Shi, Ethanolic extract of Cordyceps cicadae exerts antitumor effect on human gastric cancer SGC-7901 cells by inducing apoptosis, cell cycle arrest and endoplasmic reticulum stress, J. Ethnopharmacol. 231 (2019) 230–240. doi:10.1016/j.jep.2018.11.028.
[19] Z. Guo, W. Chen, G. Dai, Y. Huang, Cordycepin suppresses the migration and invasion of human liver cancer cells by downregulating the expression of CXCR4, Int. J. Mol. Med. 45(1) (2020) 141–150. doi:10.3892/ijmm.2019.4391.
[20] J.Y. Wan, H. Yao, C.F. Zhang, et al, Red American ginseng enhances the effect of fluorouracil on human colon cancer cells via both paraptosis and apoptosis pathways, J. Appl. Biomed. 16(4) (2018) 311–319. doi:10.1016/j.jab.2018.05.002.
[21] J.L. Gao, G.Y. Lv, B.C. He, et al, Ginseng saponin metabolite 20(S)-protopanaxadiol inhibits tumor growth by targeting multiple cancer signaling pathways, Oncol. Rep. 30(1) (2013) 292–298. doi:10.3892/or.2013.2438.
[22] X. Li, J. Tsauo, C. Geng, H. Zhao, X. Lei, X. Li, Ginsenoside Rg3 decreases NHE1 expression via inhibiting EGF-EGFR-ERK1/2-HIF-1 α pathway in hepatocellular carcinoma: A novel antitumor mechanism, Am. J. Chin. Med. 46(8) (2018) 1915–1931. doi:10.1142/S0192415X18500969.
[23] P.F. Chen, L.M. Liu, Z. Chen, S.Y. Lin, W.X. Song, Y.F. Xu, Effects of ethanol extracts of Panax notoginseng on liver metastasis of B16 melanoma grafted in mice, Zhong Xi Yi Jie He Xue Bao 4(5) (2006) 500–503. doi:10.3736/jcim20060512.
[24] N.W. He, Y. Zhao, L. Guo, J. Shang, X.B. Yang, Antioxidant, antiproliferative, and pro-apoptotic activities of a saponin extract derived from the roots of panax notoginseng (Burk.) F.H. Chen, J. Med. Food 15(4) (2012) 350–359. doi:10.1089/jmf.2011.1801.
[25] C.Z. Wang, J.T. Xie, A. Fishbein, et al, Antiproliferative effects of different plant parts of panax notoginseng on SW480 human colorectal cancer cells, Phytother. Res. 23(1) (2009) 6–13. doi:10.1002/ptr.2383.
[26] B. Kim, E.Y. Kim, E.J. Lee, et al, Panax notoginseng inhibits tumor growth through activating macrophage to M1 polarization, Am. J. Chin. Med. 46(6) (2018) 1369–1385 doi:10.1142/S0192415X18500726.
[27] L. Wang, J. Xu, Y. Yan, H. Liu, F. Li, Synthesis of gold nanoparticles from leaf panax notoginseng and its anticancer activity in pancreatic cancer PANC-1 cell lines, Artif. Cells Nanomed. Biotechnol. 47(1) (2019) 1216–1223. doi:10.1080/21691401.2019.1593852.
[28] G. Carrasco-Torres, H.C. Monroy-Ramírez, A.A. Martínez-Guerra, et al, Quercetin reverses rat liver preneoplastic lesions induced by Chemical Carcinogenesis, Oxid. Med. Cell. Longev. 2017 (2017) 4674918. doi:10.1155/2017/4674918.
[29] A.L. Hopkins, Network pharmacology, Nat. Biotechnol. 25(10) (2007) 1110–1111. doi:10.1038/nbt1007-1110.
[30] A.L. Hopkins, Network pharmacology: the next paradigm in drug discovery, Nat. Chem. Biol. 4(11) (2008) 682–690. doi:10.1038/nchembio.118.
[31] A.L. Hopkins, Network pharmacology: the next paradigm in drug discovery, Nat. Chem. Biol. 4(11) (2008) 682–690. doi:10.1038/nchembio.118.
[32] J. Ru, P. Li, J. Wang, et al, TCMSP: a database of systems pharmacology for drug discovery from herbal medicines, J. Cheminform. 6 (2014) 13. doi:10.1186/1758-2946-6-13
[33] X. Xu, W. Zhang, C. Huang, et al, A novel chemometric method for the prediction of human oral bioavailability, Int. J. Mol. Sci. 13(6) (2012) 6964–6982. doi:10.3390/ijms13066964.
[34] W.P. Walters, M.A. Murcko, Prediction of “drug-likeness”, Adv. Drug Deliv. Rev. 54(3) (2002) 255–271. doi:10.1016/S0169-409X(02)00003-0.
[35] W. Feng, H. Ao, S. Yue, C. Peng, Systems pharmacology reveals the unique mechanism features of Shenzhu Capsule for treatment of ulcerative colitis in comparison with synthetic drugs [sci. rep. 2018 8(1) 16160. doi:10.1038/s41598-018-34509-1.
[36] UniProt Consortium, UniProt: a hub for protein information, Nucleic Acids Res. 43((database issue)) (2015) D204–D212. doi:10.1093/nar/gku989.
[37] D. Gfeller, A. Grosdidier, M. Wirth, A. Daina, O. Michielin, V. Zoete, SwissTargetPrediction: a web server for target prediction of bioactive small molecules, Nucleic Acids Res. 42(Web Server issue) (Web Server Issue) (2014) W32–W38. doi:10.1093/nar/gku293.
[38] G. Stelzer, N. Rosen, I. Plaschkes, et al, The GeneCards suite: from gene data mining to disease genome sequence analyses, Curr. Protoc. Bioinformatics 54(1) (2016) 30.1–1.30.33. doi:10.1002/cpbi.5.
[39] J.S. Amberger, A. Hamosh, Searching Online Mendelian Inheritance in Man (OMIM): A KnowledgeBase of human genes and genetic phenotypes, Curr. Protoc. Bioinformatics 58(1) (2017) 2.1–1.2.12. doi:10.1002/cpbi.27.
[40] P. Shannon, A. Markiel, O. Ozier, et al, Cytoscape: a software environment for integrated models of biomolecular interaction networks, Genome Res. 13(11) (2003) 2498–2504. doi:10.1101/gr.1239303.
[41] D. Szklarczyk, J.H. Morris, H. Cook, et al, The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible, Nucleic Acids Res. 45(D1) (2017) D362–D368. doi:10.1093/nar/gkw937.
[42] Y. Assenov, F. Ramírez, S.E. Schelhorn, T. Lengauer, M. Albrecht, Computing topological parameters of biological networks, Bioinformatics 24(2) (2008) 282–284. doi:10.1093/bioinformatics/btm554.
[43] J. Liu, M. Li, X.J. Luo, B. Su, Systems-level analysis of risk genes reveals the modular nature of schizophrenia, Schizophr. Res. 201 (2018) 261–269. doi:10.1016/j.schres.2018.05.015.
[44] C. Zhang, Y. Zheng, X. Li, X. Hu, F. Qi, J. Luo, Genome-wide mutation profiling and related risk signature for prognosis of papillary renal cell carcinoma, Ann. Transl. Med. 7(18) (2019) 427. doi:10.21037/atm.2019.08.113
[45] D. Zhou, Y. Sun, Y. Jia, et al, Bioinformatics and functional analyses of key genes in smoking-associated lung adenocarcinoma, Oncol. Lett. 18(4) (2019) 3613–3622. doi:10.3892/ol.2019.10733.
[46] O. Trott, A.J. Olson, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J. Comput. Chem. 31(2) (2010) 455–461. doi:10.1002/jcc.21334.
[47] A. Khezri, A. Karimi, F. Yazdian, et al, Molecular dynamic of curcumin/chitosan interaction using a computational molecular approach: emphasis on biofilm reduction, Int. J. Biol. Macromol. 114 (2018) 972–978. doi:10.1016/j.ijbiomac.2018.03.100.
[48] H.M. Berman, J. Westbrook, Z. Feng, et al, The Protein Data Bank, Nucleic Acids Res. 28(1) (2000) 235–242. doi:10.1093/nar/28.1.235.
[49] A. Daina, O. Michielin, V. Zoete, SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules, Nucleic Acids Res. 47(W1) (2019) W357–W364. doi:10.1093/nar/gkz382
[50] K.Y. Hsin, S. Ghosh, H. Kitano, Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology, PLOS ONE 8(12) (2013) e83922. doi:10.1371/journal.pone.0083922.
[51] M. Singh, A. Maitra, Precursor lesions of pancreatic cancer: molecular pathology and clinical implications, Pancreatology 7(1) (2007) 9–19. doi:10.1159/000101873
[52] M. Löhr, G. Klöppel, P. Maisonneuve, A.B. Lowenfels, J. Lüttges, Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis, Neoplasia 7(1) (2005) 17–23. doi:10.1593/neo.04445.
[53] F. Notta, M. Chan-Seng-Yue, M. Lemire, et al, A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns, Nature 538(7625):378‐382 (2016). doi:10.1038/nature19823.
[54] K. Bishayee, S. Ghosh, A. Mukherjee, R. Sadhukhan, J. Mondal, A.R. Khuda-Bukhsh, Quercetin induces cytochrome-c release and ROS accumulation to promote apoptosis and arrest the cell cycle in G2/M, in cervical carcinoma: signal cascade and drug-DNA interaction, Cell Prolif. 46(2) (2013) 153–163. doi:10.1111/cpr.12017.
[55] A.F. Clemente-Soto, E. Salas-Vidal, C. Milan-Pacheco, J.N. Sánchez-Carranza, O. Peralta-Zaragoza, L. González-Maya, Quercetin induces G2 phase arrest and apoptosis with the activation of p53 in an E6 expression-independent manner in HPV-positive human cervical cancer-derived cells, Mol. Med. Rep. 19(3) (2019) 2097–2106. doi:10.3892/mmr.2019.9850.
[56] T. Thangasamy, S. Sittadjody, G.C. Mitchell, et al, Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73, B.M.C. Cancer 10 (2010) 282. doi:10.1186/1471-2407-10-282.
[57] Y.A. Salama, A. El-Karef, A.M. El Gayyar, N. Abdel-Rahman, Beyond its antioxidant properties: quercetin targets multiple signalling pathways in hepatocellular carcinoma in rats, Life Sci. 236 (2019) 116933. doi:10.1016/j.lfs.2019.116933.
[58] G. Carrasco-Torres, H.C. Monroy-Ramírez, A.A. Martínez-Guerra, et al, Quercetin reverses rat liver preneoplastic lesions induced by Chemical Carcinogenesis, Oxid. Med. Cell. Longev. 2017 (2017) 4674918. doi:10.1155/2017/4674918.
[59] Z. Wang, Y. Zhan, J. Xu, et al., β-sitosterol Reverses multidrug resistance via BCRP Suppression by Inhibiting the p53-MDM2 Interaction in Colorectal Cancer, J. Agric. Food Chem. 68(12) (2020) 3850–3858. doi:10.1021/acs.jafc.0c00107.
[60] P. Langer, P.H. Kann, V. Fendrich, et al, Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer, Gut 58(10) (2009) 1410–1418. doi:10.1136/gut.2008.171611.
[61] Y. Zhang, W. Yan, M.A. Collins, et al, Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance, Cancer Res. 73(20) (2013) 6359–6374. doi:10.1158/0008-5472.CAN-13-1558-T.
[62] Y. Feng, L.L. Zu, L. Zhang, MicroRNA-26b inhibits the tumor growth of human liver cancer through the PI3K/Akt and NF-κB/MMP-9/VEGF pathways, Oncol. Rep. 39(5) (2018) 2288–2296. doi:10.3892/or.2018.6289.
[63] S.S. Chen, A. Michael, S.A. Butler-Manuel, Advances in the treatment of ovarian cancer: a potential role of antiinflammatory phytochemicals, Discov. Med. 13(68) (2012) 7–17
[64] D. Yu, T. Ye, Y. Xiang, et al, Quercetin inhibits epithelial-mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial-mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells, OncoTargets Ther. 10 (2017) 4719–4729. doi:10.2147/OTT.S136840.
[65] L.H. Lian, Q. Jin, S.Z. Song, et al, Ginsenoside Rh2 downregulates LPS-induced NF− κ B activation through inhibition of TAK1 phosphorylation in RAW 264.7 murine macrophage, Evid. Based Complement. Alternat. Med. 2013 (2013) 646728. doi:10.1155/2013/646728.
[66] J. Huang, K. Peng, L. Wang, et al, Ginsenoside Rh2 inhibits proliferation and induces apoptosis in human leukemia cells via TNF-α signaling pathway, Acta Biochim. Biophys. Sin. (Shanghai) 48(8) (2016) 750–755. doi:10.1093/abbs/gmw049.
[67] A. Mohammed, N.B. Janakiram, Q. Li, et al, The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-KrasG12D/+ transgenic mouse model, Cancer Prev. Res. Phila 3(11) (2010) 1417–1426. doi:10.1158/1940-6207.CAPR-10-0038.
[68] F.A. Bhat, G. Sharmila, S. Balakrishnan, et al, Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway, J. Nutr. Biochem. 25(11) (2014) 1132–1139. doi:10.1016/j.jnutbio.2014.06.008